Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors

Steroids

Volumn 74, Issue 7, 2009, Pages 628-634

  Furuya, Fumihiko ^a   Lu, Changxue ^a   Guigon, Celine J ^a   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Mouse model; Nongenomic actions; Nuclear receptor corepressor; Phosphatidylinositol 3 kinase; Thyroid cancer; Thyroid hormone receptors

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GELATINASE A; MAMMALIAN TARGET OF RAPAMYCIN; NUCLEAR RECEPTOR COREPRESSOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; S6 KINASE; THYROID HORMONE RECEPTOR BETA;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; METASTASIS; METASTASIS INHIBITION; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THYROID CANCER;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; HUMANS; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

MAMMALIA; MUS;

EID: 63649143022     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2008.10.009     Document Type: Article

References (38)

1. Cheng S.Y. Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 1 (2000) 9-18
2. Bassett J.H., Harvey C.B., and Williams G.R. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213 (2003) 1-11
3. Yen P.M., Ando S., Feng X., Liu Y., Maruvada P., and Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246 (2006) 121-127
4. Lonard D.M., and O'malley B.W. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 27 (2007) 691-700
5. Forrest D., and Vennström B. Functions of thyroid hormone receptors in mice. Thyroid 10 (2000) 41-52
6. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of estrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
7. Hiroi Y., Kim H.H., Ying H., Furuya F., Huang Z., Simoncini T., et al. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103 (2006) 14104-14109
8. Cao X., Kambe F., Moeller L.C., Refetoff S., and Seo H. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19 (2005) 102-112
9. Kenessey A., and Ojamaa K. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281 (2006) 20666-20672
10. Storey N.M., Gentile S., Ullah H., Russo A., Muessel M., Erxleben C., et al. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci USA 103 (2006) 5197-5201
11. Verga Falzacappa C., Panacchia L., Bucci B., Stigliano A., Cavallo M.G., Brunetti E., et al. 3,5,3'-triiodothyronine (T3) is a survival factor for pancreatic beta-cells undergoing apoptosis. J Cell Physiol 206 (2006) 309-321
12. Verga Falzacappa C., Petrucci E., Patriarca V., Michienzi S., Stigliano A., Brunetti E., et al. Thyroid hormone receptor TRbeta1 mediates Akt activation by T3 in pancreatic beta cells. J Mol Endocrinol 38 (2007) 221-233
13. Zoeller R.T. Local control of the timing of thyroid hormone action in the developing human brain. J Clin Endocrinol Metab 89 (2004) 3114-3116
14. Gothe S., Wang Z., Ng L., Kindblom J.M., Barros A.C., Ohlsson C., et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13 (1999) 1329-1341
15. Parrilla R., Mixson A.J., McPherson J.A., McClaskey J.H., and Weintraub B.D. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. J Clin Invest 88 (1991) 2123-2130
16. Meier C.A., Dickstein B.M., Ashizawa K., McClaskey J.H., Muchmore P., Ransom S.C., et al. 1992 Variable transcriptional activity and ligand binding of mutant beta 1 3, 5, 3′-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6 (1991) 248-258
17. Kaneshige M., Kaneshige K., Zhu X., Dace A., Garrett L., Carter T.A., et al. Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 97 (2000) 13209-13214
18. Suzuki H., Willingham M.C., and Cheng S.Y. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12 (2002) 963-969
19. Ying H., Suzuki H., Furumoto H., Walker R., Meltzer P., Willingham M.C., et al. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Carcinogenesis 24 (2003) 1467-1479
20. Liu Z., Hou P., Ji M., Guan H., Studeman K., Jensen K., et al. Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab 93 (2008) 3106-3116
21. Furuya F., Hanover J.A., and Cheng S.Y. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc Natl Acad Sci USA 103 (2006) 1780-1785
22. Lin K.H., Parkison C., McPhie P., and Cheng Sy. An essential role of domain D in the hormone-binding activity of human b1 thyroid hormone nuclear receptor. Mol Endocrinol 5 (1991) 485-492
23. Zhang X.Y., Kaneshige M., Kamiya Y., Kaneshige K., and Cheng S.Y. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant β receptor. Mol Endocrinol 16 (2002) 2077-2092
24. Furuya F., Lu C., Willingham M.C., and Cheng S.Y. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Carcinogenesis 28 (2007) 2451-2458
25. Carnero A., Blanco-Aparicio C., Renner O., Link W., and Leal J.F. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8 (2008) 187-198
26. Persad S., and Dedhar S. The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 22 (2003) 375-384
27. Edwards L.A., Shabbits J.A., Bally M., and Dedhar S. Integrin-linked kinase (ILK) in combination molecular targeting. Cancer Treat Res 119 (2004) 59-75
28. Yoh S.M., and Privalsky M.L. Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor. Mol Cell Endocrinol 159 (2000) 109-124 [Erratum: Mol Cell Endocrinol 2000;162:235]
29. Furuya F., Guigon C.J., Zhao L., Lu C., Hanover J.A., and Cheng S.Y. Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol Cell Biol 27 (2007) 6116-6126
30. Shepherd P.R., Withers D.J., and Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333 (1998) 471-490
31. Beeton C.A., Das P., Waterfield M.D., and Shepherd P.R. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function. Mol Cell Biol Res Commun 1 (1999) 153-157
32. Kang Q., Cao Y., and Zolkiewska A. Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells. J Biol Chem 276 (2001) 24466-24472
33. Song R.X., Barnes C.J., Zhang Z., Bao Y., Kumar R., and Santen R.J. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA 101 (2004) 2076-2081
34. Pedram A., Razandi M., and Levin E.R. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20 (2006) 1996-2009
35. Pedram A., Razandi M., Sainson R.C., Kim J.K., Hughes C.C., and Levin E.R. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282 (2007) 22278-22288
36. Grossmann C., Freudinger R., Mildenberger S., Husse B., and Gekle M. EF domains are sufficient for nongenomic mineralocorticoid receptor actions. J Biol Chem 283 (2008) 7109-7116
37. Huhtakangas J.A., Olivera C.J., Bishop J.E., Zanello L.P., and Norman A.W. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha, 25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18 (2004) 2660-2671
38. Kaneshige M., Suzuki H., Kaneshige K., Cheng J., Wimbrow H., Barlow C., et al. A targeted dominant negative mutation of the thyroid hormone α1 receptor causes increased mortality, infertility and dwarfism in mice. Proc Natl Acad Sci USA 98 (2001) 15095-15100